Application Nr Approved Date Route Status External Links
ANDA201831 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Central Diabetes Insipidus: Desmopressin Acetate Tablets Are Indicated As Antidiuretic Replacement Therapy In The Management Of Central Diabetes Insipidus And For The Management Of The Temporary Polyuria And Polydipsia Following Head Trauma Or Surgery In The Pituitary Region. Desmopressin Acetate Tablets Are Ineffective For The Treatment Of Nephrogenic Diabetes Insipidus. Patients Were Selected For Therapy Based On The Diagnosis By Means Of The Water Deprivation Test, The Hypertonic Saline Infusion Test, And/or Response To Antidiuretic Hormone. Continued Response To Desmopressin Acetate Can Be Monitored By Measuring Urine Volume And Osmolality. Primary Nocturnal Enuresis: Desmopressin Acetate Tablets Are Indicated For The Management Of Primary Nocturnal Enuresis. Desmopressin Acetate Tablets May Be Used Alone Or As An Adjunct To Behavioral Conditioning Or Other Non-Pharmacologic Intervention.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Desmopressin Acetate

Comments